SNG001 just became a lot more valuable9 Oct 2020 07:16
Part 1
Some very interesting posts in here yesterday. All studies are pointing towards the over-activation of the immune system through the upregulation of anaphylatoxins C5a and C3a, which in turn downregulate the body's natural production of interferon beta-1a, as the main driver behind 'long covid' and higher mortality outcomes.
Very importantly - It would seem that our 'caterpillar drug' has yet another leg to stand on as a PREVENTATIVE drug given to people, and high risk groups BEFORE a Covid-19 infection.
Think of it as a natural 'vaccine' without the adverse side effects or the over-activation of the immune system.
Andreas Wack, immunologist at the Francis Crick Institute says:
"Every study in every species has shown that if you induce interferons before [a] virus comes in, the virus loses”. “The earlier you can give it, the better, and the best thing you can do is to give it before the virus is there.”
The science certainly backs it up as looking into the 'bat model' it shows that bats remain unaffected by coronavirus due to their natural high levels of interferon beta-1a. If you could illicit the same levels of interferon beta-1a in humans - particularly those with lower interferon beta-1a levels - the virus would be stopped before it was even able to take hold.
I have read several recent papers recently, and discussed it at work, showing that this preventative drug measure with interferon beta-1a for Covid-19 is being looked at as the PRIMARY prevention method towards protecting high risk groups. This opens up a whole new market for SNG001 as it is the superior bioavailable form of interferon beta-1a with fewest side effects. And SNG001 is the only safe preventative therapeutic that can be given to high risk groups, and it can be administered at home for people in insolation. Unlike IV interferon beta-1a, SNG001 is also proven to work extremely well with steroids. Not to mention it is also patented for use with steroids.
The fact that it can be used before infection as a 'vaccine' towards Covid-19, especially in high risk groups or people unable or the growing number of people unwilling to get a vaccine, is incredibly unique and puts SNG001 in a market of it's own.
SNG001 just became a lot more valuable than any of us thought. We are now talking about a drug that can be used BEFORE, in the beginning, during with dexamethasone and remdesvir, and after infection to treat and heal the effects of 'long covid'.